HPI Tuesday seminar: Hormonal modulation of toll-like receptor signaling // CRISPR/Cas9-derived activator systems as novel approaches to overcome HIV latency // Revealing cellular and viral interaction partners of the multifunctional HAdV Type 5 E4orf3